PenderFund Capital Management Ltd.
Position in MRVI — Maravai Lifesciences Holdings, Inc.
CIK 1706164
VANCOUVER, A1
Position in MRVI
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$580,150
-$136,475 QoQ
Shares Held
205,000
-7.0% QoQ
Ownership
0.079%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2022
8 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in MRVI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PenderFund Capital Management Ltd. holds $2,724,879 across 7 Biotechnology names. MRVI ranks #2 (21.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | FOLD |
AMICUS THERAPEUTICS, INC.
|
41,100 | $594,306 | |
| 2 | MRVI |
Maravai Lifesciences Holdings, Inc.
This page
|
205,000 | $580,150 | |
| 3 | DAWN |
Day One Biopharmaceuticals, Inc.
|
26,800 | $574,592 | |
| 4 | XENE |
Xenon Pharmaceuticals Inc.
|
6,850 | $398,327 | |
| 5 | ACLX |
Arcellx, Inc.
|
2,900 | $332,978 | |
| 6 | LSTA |
Lisata Therapeutics, Inc.
|
47,500 | $237,975 | |
| 7 | RNA |
Atrium Therapeutics, Inc.
|
490 | $6,551 |
All Filings in MRVI
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $580,150 | 205,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $716,625 | 220,500 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,204,989 | 419,857 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,097,182 | 870,200 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,826,123 | 826,300 | Shares | Sole | 2025-08-14 | |
| 2024-12-31 | $3,162,635 | 580,300 | Shares | Sole | 2025-02-14 | |
| 2022-09-30 | $30,636 | 1,200 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $34,092 | 1,200 | Shares | Sole | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||